I

Indiana University

Indiana University radiologists detect 65% more cancers with iCAD ProFound AI for digital breast tomosynthesis

Curated & reviewed by Peter Korpak, Founder & Chief Analyst, 100SignalsHow we verify
65% more cancers detectedCancer Detection Rate Improvement
57% with AI vs. 32% withoutBiopsy PPV (PPV3)
Reduced from 8.2% to 6.5%Abnormal Interpretation Rate

Vendor-reported figures — source: www.itnonline.com

Indiana University
Metric Before After Impact
Biopsy Positive Predictive Value (PPV3) 32% 57% 78% improvement
Abnormal Interpretation Rate 8.2% 6.5% 21% reduction
PPV for Abnormal Interpretations (PPV1) 4.2% 8.8% 2.1x improvement
Cancer Detection Rate 65% increase 65% more cancers detected

The Challenge

Radiologists faced challenges in accurately detecting breast cancer in digital breast tomosynthesis (DBT) scans, with high false-positive rates leading to unnecessary patient callbacks. Rising breast cancer rates, particularly among younger women, increased the urgency for more accurate and efficient screening workflows.

The Solution

iCAD's ProFound AI deep-learning system was implemented to support radiologists interpreting 3D mammography (DBT) scans. The system flags suspicious findings while integrating into existing radiologist workflows, enabling AI-assisted review of DBT cases across more than 16,000 exams.

Results

Radiologists using ProFound AI identified 65% more cancers compared to without AI. Positive Predictive Value for abnormal interpretations (PPV1) doubled from 4.2% to 8.8%, and PPV3 for biopsies improved from 32% to 57%. The abnormal interpretation rate dropped from 8.2% to 6.5%, reducing unnecessary callbacks.

Key Takeaways

  • Deep-learning AI integrated into radiologist workflows can simultaneously improve cancer detection rates and reduce false positives, resolving a traditional sensitivity-specificity tradeoff.
  • PPV improvements (PPV1 doubling, PPV3 near doubling) indicate AI helps radiologists act on findings with greater confidence, reducing unnecessary biopsies.
  • Real-world peer-reviewed studies across 16,000+ cases validate AI imaging tools as clinical assets, not just research tools.

Share:

Details

Company Size
Enterprise
Quality
Curated
Last verified
Jul 28, 2026

Have a similar implementation?

Share your customer's AI results and link it to your vendor profile.

Submit a case study →